Bonk, Inc. (NASDAQ:BNKK – Get Free Report) was the recipient of a large decline in short interest in May. As of May 29th, there was short interest totaling 426,285 shares, a decline of 48.9% from the May 14th total of 834,243 shares. Approximately 11.0% of the company’s stock are short sold. Based on an average trading volume of 547,519 shares, the days-to-cover ratio is currently 0.8 days.
Insider Activity at Bonk
In other news, Director Mitchell Austin Rudy acquired 31,055 shares of Bonk stock in a transaction that occurred on Thursday, April 9th. The stock was purchased at an average price of $2.82 per share, for a total transaction of $87,575.10. Following the purchase, the director directly owned 44,198 shares in the company, valued at $124,638.36. The trade was a 236.29% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 51.60% of the stock is currently owned by company insiders.
Institutional Trading of Bonk
Several large investors have recently bought and sold shares of BNKK. State Street Corp purchased a new stake in Bonk during the 4th quarter worth approximately $33,000. Steward Partners Investment Advisory LLC purchased a new stake in Bonk during the 4th quarter worth approximately $37,000. Jane Street Group LLC purchased a new stake in Bonk during the 4th quarter worth approximately $96,000. Finally, Geode Capital Management LLC purchased a new stake in Bonk during the 4th quarter worth approximately $128,000. Hedge funds and other institutional investors own 12.55% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Analysis on Bonk
Bonk Trading Down 4.3%
NASDAQ:BNKK opened at $1.35 on Friday. The company has a market cap of $10.80 million, a PE ratio of -0.29 and a beta of 1.85. Bonk has a twelve month low of $1.25 and a twelve month high of $46.90. The company’s 50 day moving average is $2.26 and its two-hundred day moving average is $3.26.
Bonk (NASDAQ:BNKK – Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. The company had revenue of $0.79 million for the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.
About Bonk
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
Featured Stories
- Five stocks we like better than Bonk
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
